Unit of Atherosclerosis Prevention

Selected Projects

best publications in the last three years

• • Porro B, Eligini S, Veglia F, Lualdi A, Squellerio I, Fiorelli S, Giovannardi M, Chiorino E, Dalla Cia A, Crisci M, Werba JP, Tremoli E, Cavalca V. Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress. Oxid Med Cell Longev 2014;2014:726539.
  • Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, Myasoedova V, Takeuchi K, Adachi E, Inui N, Tremoli E, Watanabe H. Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des 2015;21(9):1213-1219.
  • Ravani A, Werba JP, Frigerio B, Sansaro D, Amato M, Tremoli E, Baldassarre D. Assessment and Relevance of Carotid Intima-Media Thickness (C-IMT) in Primary and Secondary Cardiovascular Prevention. Curr Pharm Des 2015;21(9):1164-1171.
  • Marenzi G, Cosentino N, Werba JP, Tedesco CC, Veglia F, Bartorelli AL. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol 2015;183C:47-53.
  • Amadio P, Colombo GI, Tarantino E, Gianellini S, Ieraci A, Brioschi M, Banfi C, Werba JP, Parolari A, Lee FS, Tremoli E, Barbieri SS. BDNFVal66met polymorphism: a potential bridge between depression and thrombosis. Eur Heart J 2015 Dec 24 [Epub ahead of print]
  • Banerjee A, Khandelwal S, Nambiar L, Saxena M, Peck V, Moniruzzaman M, Faria Neto JR, Quinto KC, Smyth A, Leong D, Werba JP. Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review. Open Heart 2016;3(2):e000438.

Staff

• Lorenzo Vigo, MD

  Monica Giroli, Biologist Nutritionist, Ph.D

  Manuela Amato, MSc

  Nicolò Simonelli, PhD, Research Nurse